Drugs Giant Attacked Over Anti-Depressant Dangers ; Gsk 'Withheld Information Over Suicide Risk'
Linked as:
Summary
HEALTH regulators yesterday criticised drugs firm Glaxosmithkline (GSK) for withholding information over the risk of suicide relating to one of its antidepressant drugs.
The Medicines and Healthcare Products Regulatory Agency (MHRA) said it remained concerned that GSK failed to raise the alarm earlier over the side-effects of Seroxat.See the full content of this document
Extract
Drugs Giant Attacked Over Anti-Depressant Dangers ; Gsk 'Withheld Information Over Suicide Risk'
Government prosecutors have ruled that there is no realistic prospect of getting a conviction over the issue.
But new legislation ensuring drugs companies pas...See the full content of this document
Sponsored links
